The proteasome inhibitor bortezomib (Velcade) sensitizes some human tumor cells to Apo2L/TRAIL-mediated apoptosis. [electronic resource]
Producer: 20060622Description: 160-7 p. digitalISSN:- 0077-8923
- Antineoplastic Agents -- pharmacology
- Apoptosis
- Apoptosis Regulatory Proteins -- metabolism
- Boronic Acids -- pharmacology
- Bortezomib
- Cell Line, Tumor
- Dose-Response Relationship, Drug
- Humans
- Ligands
- Membrane Glycoproteins -- metabolism
- Neoplasms -- metabolism
- Proteasome Inhibitors
- Pyrazines -- pharmacology
- TNF-Related Apoptosis-Inducing Ligand
- Tumor Necrosis Factor-alpha -- metabolism
- Tumor Suppressor Protein p53 -- metabolism
- bcl-2-Associated X Protein -- metabolism
No physical items for this record
Publication Type: Journal Article; Research Support, N.I.H., Extramural
There are no comments on this title.
Log in to your account to post a comment.